Solaris Asset Management’s AbbVie ABBV Stock Holding History

Solaris Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-436	Closed	-$27K	–	481
2016 Q2	$27K	Hold	436	–	–	0.02%	164
2016 Q1	$25K	Hold	436	–	–	0.02%	159
2015 Q4	$26K	Hold	436	–	–	0.02%	149
2015 Q3	$24K	Buy	436 +29	+7%	+$1.89K	0.02%	147
2015 Q2	$27K	Buy	407 +7	+2%	+$457	0.02%	195
2015 Q1	$23K	Hold	400	–	–	0.01%	193
2014 Q4	$26K	Hold	400	–	–	0.02%	184
2014 Q3	$23K	Hold	400	–	–	0.02%	186
2014 Q2	$23K	Hold	400	–	–	0.02%	182
2014 Q1	$21K	Hold	400	–	–	0.01%	172
2013 Q4	$21K	Hold	400	–	–	0.01%	206
2013 Q3	$18K	Hold	400	–	–	0.01%	206
2013 Q2	$17K	Buy	+400	New	+$17.5K	0.01%	212

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Solaris Asset Management's ABBV Position: Q3 2016 in Review

Solaris Asset Management sold out of AbbVie (ABBV) in Q3 2016, closing a stake of 436 shares — an estimated $27K sold.

Solaris Asset Management first reported a position in ABBV in Q2 2013 and held it in 13 quarters. The position peaked at $27K in Q2 2016. 1,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2016.

Solaris Asset Management reported no remaining AbbVie position as of Q3 2016 after selling out during the quarter.
Solaris Asset Management sold 436 AbbVie shares in Q3 2016, an estimated $27K.
Solaris Asset Management first reported a position in AbbVie in Q2 2013 and held it in 13 quarters.
Solaris Asset Management's AbbVie position peaked at $27K in Q2 2016.
1,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2016.

Based on Solaris Asset Management's 13F filing for Q3 2016, filed 24 Oct 2016.